Universal Biosensors Email Formats
Biotechnology Research • 
Melbourne, Victoria, Australia • 51-100 Employees
Universal Biosensors Email Formats
Universal Biosensors uses 4 email formats. The most common is {first initial}{last name} (e.g., jdoe@universalbiosensors.com), used 53.5% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@universalbiosensors.com | 53.5% |
{first name}{last name} | johndoe@universalbiosensors.com | 41.9% |
{first initial}{second initial}{last name} | jodoe@universalbiosensors.com | 2.3% |
{last name}{last name} | doedoe@universalbiosensors.com | 2.3% |
Key Contacts at Universal Biosensors
John Sharman
Chief Executive Officer
David Burroughes
Commercial Director Eu
Keith Sims
Global Marketing Director
Peter Mullin
Ceo & Managing Director
Luke Cossins
Chief Technology Officer
Company overview
| Headquarters | 1 Corporate Ave, Rowville, Melbourne, Vic 3178, AU |
| Phone number | +61392139000 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | New Product Development, Iso 13485, Biosensors, Electrochemical Sensors, Blood Coagulation Testing Systems, Blood Glucose Testing Systems, Diagnostic Test Systems, Point-Of-Care Diagnostics |
| Founded | 2002 |
| Employees | 51-100 |
| Socials |
About Universal Biosensors
Universal Biosensors Inc (UBI) is a global biosensor company and a world leader in electrochemical cell technology. UBI’s ambition is to utilize its patented biosensor technology to develop a diverse range of biosensor test strips used in our hand-held portable analyzers; for cost effective, effortless, and accurate detection of analytes of interest, within many industries including human health, animal health, environmental, and agriculture. UBI is a USA Delaware company listed on the Australian Securities Exchange (ASX:UBI) and operates from its head office, manufacturing facility, and research laboratory in Melbourne, Victoria, Australia. In 2021, UBI successfully launched its unique handheld wine analyzer called Sentia™ with an initial test to measure free SO2 , and subsequently in 2022, tests for monitoring malic acid and glucose throughout the wine production process (more tests in the pipeline are due for release in late 2022). In 2022, UBI launched Xprecia Prime™ in the EU and UK, the next-generation blood coagulation analyzer which replaces Xprecia Stride™. Xprecia Prime™ is due for launch in the US in 2023. UBI is due to launch Petrackr™ in late 2022/early 2023, a veterinary blood glucometer to monitor diabetes in cats and dogs. These products will complement UBI’s existing Canadian blood testing laboratory Hemostasis Reference Lab (HRL).
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Universal Biosensors has 40 employees across 8 departments.
Departments
Number of employees
Universal Biosensors Tech Stack
Discover the technologies and tools that power Universal Biosensors's digital infrastructure, from frameworks to analytics platforms.
Security
Security
JavaScript libraries
Maps
JavaScript libraries
CDN
JavaScript libraries
Analytics
Advertising
Miscellaneous
Spain
United States
Frequently asked questions
4.8
40,000 users
